Donor‐Derived Engineered Microvessels for Cardiovascular Risk Stratification of Patients with Kidney Failure

Mitesh L. Rathod,Wen Yih Aw,Stephanie Huang,Jingming Lu,Elizabeth L. Doherty,Chloe P. Whithworth,Gang Xi,Prabir Roy‐Chaudhury,William J. Polacheck

DOI: https://doi.org/10.1002/smll.202307901

IF: 13.3

2024-01-09

Small

Abstract:Cardiovascular disease events account for ≈50% of all deaths in stage 4 and 5 chronic kidney disease. A challenge in understanding the mechanisms relating chronic kidney disease to cardiovascular disease is the lack of models that allow screening the effects of the uremic environment on the endothelium. Here, donor‐derived engineered microvessels are reported to quantitatively assess the impact of uremic toxins on vascular barrier function. Cardiovascular disease is the cause of death in ≈50% of hemodialysis patients. Accumulation of uremic solutes in systemic circulation is thought to be a key driver of the endothelial dysfunction that underlies elevated cardiovascular events. A challenge in understanding the mechanisms relating chronic kidney disease to cardiovascular disease is the lack of in vitro models that allow screening of the effects of the uremic environment on the endothelium. Here, a method is described for microfabrication of human blood vessels from donor cells and perfused with donor serum. The resulting donor‐derived microvessels are used to quantify vascular permeability, a hallmark of endothelial dysfunction, in response to serum spiked with pathophysiological levels of indoxyl sulfate, and in response to serum from patients with chronic kidney disease and from uremic pigs. The uremic environment has pronounced effects on microvascular integrity as demonstrated by irregular cell–cell junctions and increased permeability in comparison to cell culture media and healthy serum. Moreover, the engineered microvessels demonstrate an increase in sensitivity compared to traditional 2D assays. Thus, the devices and the methods presented here have the potential to be utilized to risk stratify and to direct personalized treatments for patients with chronic kidney disease.

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology